Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon

NCT05935527 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Lower Eyelid Steatoblepharon

Interventions

DRUG: POLAT-001
DRUG: Placebo

Sponsor

Peregrine Ophthalmic